CRA presents at AXS25 "GLP-1s: Riding the Wave of Innovative Medications"
Read the key takeaways here.
Industries
Life Sciences
We bring clarity to complex challenges.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
Engagements
- 01Economic and commercial considerations for a preliminary injunction in EuropeCRA experts were retained by counsel for the plaintiff in connection with an application for a preliminary injunctionView engagement
- 02Calculation of deduction in IRS tax disputeCRA experts were retained by a large US-based company in a tax dispute with the IRS.View engagement
- 03Prospective damages evaluation for breach of a co-promotion agreementCRA experts were retained on behalf of a multinational biopharmaceutical manufacturer to evaluate expected damages from terminating a co-promotion agreementView engagement
Contact a Life Sciences expert.
See all Life Sciences expertsLatest insights
Upcoming events
ACI 12th Annual Summit for Women Leaders in Life Sciences Law
CRA is a proud sponsor of the conference that aims to increase the prominence of women through professional development, substantive legal discussion, and...
6th ESCMID Conference on Vaccines "From development to real-world clinical practice and global health"
Abhishek Kumar presents his poster titled “Top Trends Affecting the Vaccines Market and their Implications on Access Policy and Public Health...
Recent events
ABA Webinar: "Balancing Caregiving and Professional Goals"
Erin McDermott moderates the session exploring practical strategies for balancing caregiving responsibilities with professional goals. Caring for a parent,...
Getting to Know CRA’s Academic Experts: Zack Cooper
Is Going to a Private-Equity Owned Hospital Bad for Your Health? Private equity investment in health care has increased more than 20-fold—from $5 billion in...